Oliveira, R., Coelho, A., Charrua, A., Avelino, A., & Cruz, F. (2017). Expression of cleaved SNAP-25 after bladder wall injection of onabotulinumtoxina or abobotulinumtoxina: A comparative study in the mice. Neurourology and Urodynamics, 36(1), 86 - 90.

Matos, R., Serrão, P., Rodriguez, L., Birder, L. A., et al. (2017). The water avoidance stress induces bladder pain due to a prolonged alpha1A adrenoceptor stimulation. Naunyn-Schmiedeberg's Archives of Pharmacology, 390(8), 839 - 844.

Matos, R., Cordeiro, J. M., Coelho, A., Ferreira, S., et al. (2016). Bladder pain induced by prolonged peripheral alpha 1A adrenoceptor stimulation involves the enhancement of transient receptor potential vanilloid 1 activity and an increase of urothelial adenosine triphosphate release. Acta Physiologica, 218(4), 265 - 275.

Silva, M., Martins, D., Charrua, A., Piscitelli, F., et al. (2016). Endovanilloid control of pain modulation by the rostroventromedial medulla in an animal model of diabetic neuropathy. Neuropharmacology, 107, 49 - 57.

Charrua, A., Pinto, R., Taylor, A., Canelas, A., et al. (2015). Can the adrenergic system be implicated in the pathophysiology of bladder pain syndrome/interstitial cystitis? A clinical and experimental study. Neurourology and Urodynamics, 34(5), 489 - 496.

Charrua, A., Cruz, C. D., Jansen, D., Rozenberg, B., et al. (2015). Co-administration of transient receptor potential vanilloid 4 (TRPV4) and TRPV1 antagonists potentiate the effect of each drug in a rat model of cystitis. BJU International, 115(3), 452 - 460.

Charrua, A., & Cruz, F. (2015). Intravesical Capsaicin and Resiniferatoxin for Bladder Disorders. In TRP Channels as Therapeutic Targets: From Basic Science to Clinical Use (pp. 119 - 127).

Frias, B., Allen, S., Dawbarn, D., Charrua, A., et al. (2013). Brain-derived neurotrophic factor, acting at the spinal cord level, participates in bladder hyperactivity and referred pain during chronic bladder inflammation. Neuroscience, 234, 88 - 102.

Avelino, A., Charrua, A., Frias, B., Cruz, C., et al. (2013). Transient receptor potential channels in bladder function. Acta Physiologica, 207(1), 110 - 122.

Gorgal, T., Charrua, A., Silva, J. F., Avelino, A., et al. (2012). Expression of apoptosis-regulating genes in the rat prostate following botulinum toxin type a injection. BMC Urology, 12.

Santos-Silva, A., Charrua, A., Cruz, C. D., Gharat, L., et al. (2012). Rat detrusor overactivity induced by chronic spinalization can be abolished by a transient receptor potential vanilloid 1 (TRPV1) antagonist. Autonomic Neuroscience: Basic and Clinical, 166(1-2), 35 - 38.

Frias, B., Charrua, A., Avelino, A., Michel, M. C., et al. (2012). Transient receptor potential vanilloid 1 mediates nerve growth factor-induced bladder hyperactivity and noxious input. BJU International.

Charrua, A., Avelino, A., & Cruz, F. (2011). Modulation of urinary bladder innervation: TRPV1 and botulinum toxin A. Handbook of Experimental Pharmacology (Vol. 202, pp. 345 - 374).

Charrua, A., Reguenga, C., Cordeiro, J. M., Correiade-Sá, P., et al. (2009). Functional Transient Receptor Potential Vanilloid 1 is Expressed in Human Urothelial Cells. Journal of Urology, 182(6), 2944 - 2950.

Charrua, A., Cruz, C. D., Narayanan, S., Gharat, L., et al. (2009). GRC-6211, a New Oral Specific TRPV1 Antagonist, Decreases Bladder Overactivity and Noxious Bladder Input in Cystitis Animal Models. Journal of Urology, 181(1), 379 - 386.

Charrua, A., Reguenga, C., Paule, C. C., Nagy, I., et al. (2008). Cystitis is associated with TRPVIb-downregulation in rat dorsal root ganglia. NeuroReport, 19(15), 1469 - 1472.

Cruz, C. D., Charrua, A., Vieira, E., Valente, J., et al. (2008). Intrathecal delivery of resiniferatoxin (RTX) reduces detrusor overactivity and spinal expression of TRPV1 in spinal cord injured animals. Experimental Neurology, 214(2), 301 - 308.

Baiou, D., Santha, P., Avelino, A., Charrua, A., et al. (2007). Neurochemical characterization of insulin receptor-expressing primary sensory neurons in wild-type and vanilloid type 1 transient receptor potential receptor knockout mice. Journal of Comparative Neurology, 503(2), 334 - 347.

Charrua, A., Cruz, C. D., Cruz, F., & Avelino, A. (2007). Transient Receptor Potential Vanilloid Subfamily 1 is Essential for the Generation of Noxious Bladder Input and Bladder Overactivity in Cystitis. Journal of Urology, 177(4), 1537 - 1541.

Dinis, P., Charrua, A., Avelino, A., Nagy, I., et al. (2005). The distribution of sensory fibers immunoreactive for the TRPV1 (capsaicin) receptor in the human prostate. European Urology, 48(1), 162 - 167.

Dinis, P., Charrua, A., Avelino, A., Yaqoob, M., et al. (2004). Anandamide-evoked activation of vanilloid receptor 1 contributes to the development of bladder hyperreflexia and nociceptive transmission to spinal dorsal horn neurons in cystitis. Journal of Neuroscience, 24(50), 11253 - 11263.

Dinis, P., Charrua, A., Avelino, A., & Cruz, F. (2004). Intravesical resiniferatoxin decreases spinal c-fos expression and increases bladder volume to reflex micturition in rats with chronic inflamed urinary bladders. BJU International, 94(1), 153 - 157.